MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Behind the Prison Gates – Creating a nurse led Parkinson’s healthcare pathway at HMP Dartmoor Prison, UK.

    E. Edwards, J. Bradley, B. Morgan (Plymouth, United Kingdom)

    Objective: To create an equitable Parkinson’s nurse service for people with Parkinson's detained at a Category C, men’s prison in West Devon, UK. Background: There…
  • 2024 International Congress

    Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment

    C. Schrader (Hannover, Germany)

    Objective: To objectively assess mobility and gait parameters in the ON and OFF state in patients with advanced Parkinson's disease (PD) under everyday conditions using…
  • 2024 International Congress

    Enhancing iRBD diagnosis through 2D video analysis: a machine learning approach

    M. Abdelfattah, O. Sum-Ping, J. Galati, S. Marwaha, A. Alahi, E. During (Lausanne, Switzerland)

    Objective: Evaluate the performance of a classifier using computer vision trained on video-polysomnography (vPSG) data recorded in the sleep laboratory setting over a single night…
  • 2024 International Congress

    TOPAS-MSA: Targeting Oligomer Pathology of Alpha-Synuclein – A Study Evaluating the Safety and Efficacy of Emrusolmin in Patients with Multiple System Atrophy

    J. Levin, T. Matthias, H. Knebel, S. Barash, L. Marinelli, A. Ahn, A. Giese, M. Chen, J. Nettleship ()

    Objective: The objective of the TOPAS-MSA study is to assess the safety and efficacy of emrusolmin (anle138b/TEV-56286), an orally bioavailable small molecule targeting aggregated α-synuclein,…
  • 2024 International Congress

    Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD

    H. Karkourian, L. Atabekyan, N. Nadryan, E. Balian, A. Grigoryan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: To discover whether having probable rapid eye movement sleep behavior disorder (RBD) affects prevalence of particular autonomic symptoms, namely falls, constipation and urinary incontinence…
  • 2024 International Congress

    Clinical characteristics and Brain atrophy pattern in the prospective multicenter cohort of Progressive Supranuclear Palsy

    S. Lee, R. Kim, B. Jin, H. Kim, EJ. Yoon, YK. Kim, JH. Shin, HJ. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aims to investigate volumetric brain MRI features, clinical parameters and their correlations in the Study of Comprehensive ANd multimodal marker-based Cohort of…
  • 2024 International Congress

    Metabolic Covariance Networks in Progressive Supranuclear Palsy Revealed by Spatial independent component analysis

    B. Wang, H. Wang, W. Luo (Hangzhou, China)

    Objective: The study aims to apply S-ICA to 18F-fluorodeoxyglucose (FDG) data in progressive supranuclear palsy (PSP) patients,  identifing PSP-specific independent metabolic covariate networks. We also…
  • 2024 International Congress

    Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

    A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)

    Objective: To study mechanisms of cellular inflammation and neurodegeneration of EVs derived from patients with PD at different disease stages in cell-based disease models. Background:…
  • 2024 International Congress

    Progression of motor asymmetry in the MDS-UPDRS III in Parkinson’s Disease with and without REM Sleep Behavior Disorder over five years

    S. Elasfar, H. Hameed, K. Ehgoetz-Martens (Waterloo, Canada)

    Objective: To compare progression of motor asymmetry using the MDS-UPDRS-III in Parkinson’s Disease (PD) with and without probable REM Sleep Behavior disorder (pRBD) over 5…
  • 2024 International Congress

    Concordance of Neuropathologic Diagnosis of Lewy Body Disease with Baseline Alpha-Synuclein Seed Amplification Assay in PPMI

    K. Poston, J. Ha, T. Montine, S. Bukhari, T. Foroud, L. Heathers, K. Nudelman, I. Aldecoa, A. Garrido, J. Franz, C. Stadelmann, J-P. Vonsattel, A. Siderowf, L. Chahine, T. Simuni, K. Marek (Stanford, USA)

    Objective: To determine whether the alpha-synuclein seed amplification assay (aSyn-SAA) performed on cerebral spinal fluid (CSF) collected at the baseline (BL) PPMI visit is concordant…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley